A novel expression vector for the secretion of abaecin in Bacillus subtilis
AUTOR(ES)
Li, Li, Mu, Lan, Wang, Xiaojuan, Yu, Jingfeng, Hu, Ruiping, Li, Zhen
FONTE
Braz. J. Microbiol.
DATA DE PUBLICAÇÃO
2017-12
RESUMO
ABSTRACT This study aimed to describe a Bacillus subtilis expression system based on genetically modified B. subtilis. Abaecin, an antimicrobial peptide obtained from Apis mellifera, can enhance the effect of pore-forming peptides from other species on the inhibition of bacterial growth. For the exogenous expression, the abaecin gene was fused with a tobacco etch virus protease cleavage site, a promoter Pglv, and a mature beta-glucanase signal peptide. Also, a B. subtilis expression system was constructed. The recombinant abaecin gene was expressed and purified as a recombinant protein in the culture supernatant. The purified abaecin did not inhibit the growth of Escherichia coli strain K88. Cecropin A and hymenoptaecin exhibited potent bactericidal activities at concentrations of 1 and 1.5 µM. Combinatorial assays revealed that cecropin A and hymenoptaecin had sublethal concentrations of 0.3 and 0.5 µM. This potentiating functional interaction represents a promising therapeutic strategy. It provides an opportunity to address the rising threat of multidrug-resistant pathogens that are recalcitrant to conventional antibiotics.
Documentos Relacionados
- Transcription and translation of foreign genes in Bacillus subtilis by the aid of a secretion vector.
- Engineering and production of streptokinase in a Bacillus subtilis expression-secretion system.
- Conversion of sub-megasized DNA to desired structures using a novel Bacillus subtilis genome vector
- Molecular cloning of a thermostable neutral protease gene from Bacillus stearothermophilus in a vector plasmid and its expression in Bacillus stearothermophilus and Bacillus subtilis.
- Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases.